Dudediligence.

Cocrystal Pharma, Inc

COCPNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$225,000Mar ’26$105,000Jun ’26
Net income, by quarter
−$4.9MSep ’24−$3.3MDec ’24−$2.3MMar ’25−$2.1MJun ’25−$2.0MSep ’25−$2.4MDec ’25−$2.3MMar ’26−$3.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$14.2M−$38.8M−$18.6M−$17.9M−$9.0M
Net income−$14.2M−$38.8M−$18.0M−$17.5M−$8.8M
Operating cash flow−$12.7M−$21.4M−$14.7M−$16.5M−$8.2M
Free cash flow−$12.8M−$21.5M−$14.8M−$16.5M−$8.2M
Cash$58.7M$37.1M$26.4M$9.9M$7.0M
Shares outstanding8.1M8.1M10.2M10.2M13.8M